All Cancer articles – Page 6
-
News
Fears that gene-editing cancer trials are premature
Warnings from geneticists that Crispr trial failures could knock promising technique’s prospects
-
Business
DuPont found liable in third bellwether cancer case
US court orders firm to pay $2m in damages to man whose disease has been linked to contaminated water supply
-
Podcast
Bromodeoxyuridine
Kat Arney illuminates the story of a molecular ‘highlighter pen’ for growing cells
-
News
WHO cancer agency criticised for outdated chemical risk methods
Criticism of carcinogenicity assessments that place processed meat in the same category as mustard gas
-
Podcast
PARP: Poly (ADP-ribose) polymerase
Kat Arney explains how a protein that repairs broken DNA holds the key to killing cancer cells – but only if you stop it from doing its job
-
-
Research
Connectosomes smuggle drugs across membranes
Engineered vesicles could cut drug side-effects by delivering them straight into cells using cellular ‘airlocks’
-
Podcast
Fluorouracil
A substitute for one of the bases in DNA that can cause the death of cancer cells
-
Research
Tumour cells' last breaths dampen down immune system
Dying cancer cells release potassium ions that alter the behaviour of T-cells
-
Research
Nanoplasters get cells into sticky situation
Nanoparticles that glue cells together could aid wound healing or stop tumour metastasis
-
Business
Novartis reshuffle puts 120 staff at risk
Commitment to gene and cell therapy treatments emphasised as unit broken up amid pharmaceutical division refocus
-
Business
Pfizer gambles on $14bn Medivation deal
Cancer specialist likely just one target in hunt for marketed drugs to offset patent expiries
-
Research
Magnetic fields deliver cancer-killing bacteria to tumour’s heart
Guided microbes packed with drugs can reach the parts of cancers that other drugs just can’t reach
-
Business
Amgen and Advaxis partner on immuno-oncology
Deal covers rights to system for building cancer therapies specific to a patient’s own tumours
-
Business
Celgene and Jounce team up against cancer
Firms promise next-generation immuno-oncology as existing drugs rack up successes
-
Business
Juno CAR-T trial suspended after patient deaths
Immunotherapy study restarted with amended pre-treatment protocol
-
Business
Novartis partners with Xencor for cancer antibodies
Deal deepens Novartis’s focus on immuno-oncology
-
Research
Nanoprobes to guide cancer radiotherapy dosing
Real-time Sers monitoring of radiation treatment in a 3D prostate cancer model
-
Business
Jazz Pharma buy out Celator in $1.5bn deal
Deal centres on promising leukaemia drug fast-tracked by the US Food and Drug Administration
-
Business
WHO clarifies glyphosate risks
UN and WHO panel conclude the herbicide glyphosate is ‘unlikely’ to cause cancer at realistic exposure levels